Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Regulatory T cell content in the bone marrow graft does not predict the occurrence of acute GVHD.

Rosenzwajg M, Dhédin N, Maury S, Bensimon G, Landau DA, Norol F, Trébéden-Negre H, Uzunov M, Vernant JP, Klatzmann D, Cohen JL.

Biol Blood Marrow Transplant. 2011 Feb;17(2):265-9. doi: 10.1016/j.bbmt.2010.07.024. Epub 2010 Aug 5.

2.

Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).

Champlin RE, Schmitz N, Horowitz MM, Chapuis B, Chopra R, Cornelissen JJ, Gale RP, Goldman JM, Loberiza FR Jr, Hertenstein B, Klein JP, Montserrat E, Zhang MJ, Ringdén O, Tomany SC, Rowlings PA, Van Hoef ME, Gratwohl A.

Blood. 2000 Jun 15;95(12):3702-9.

3.

T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation.

Wang XN, Taylor PR, Skinner R, Jackson GH, Proctor SJ, Hedley D, Dickinson AM.

Transplantation. 2000 Aug 15;70(3):488-93.

PMID:
10949192
5.

Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.

van Rood JJ, Loberiza FR Jr, Zhang MJ, Oudshoorn M, Claas F, Cairo MS, Champlin RE, Gale RP, Ringdén O, Hows JM, Horowitz MH.

Blood. 2002 Mar 1;99(5):1572-7.

6.
7.

CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.

Atanackovic D, Cao Y, Luetkens T, Panse J, Faltz C, Arfsten J, Bartels K, Wolschke C, Eiermann T, Zander AR, Fehse B, Bokemeyer C, Kroger N.

Haematologica. 2008 Mar;93(3):423-30. doi: 10.3324/haematol.11897. Epub 2008 Feb 20.

8.

Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study.

Gallardo D, de la Cámara R, Nieto JB, Espigado I, Iriondo A, Jiménez-Velasco A, Vallejo C, Martín C, Caballero D, Brunet S, Serrano D, Solano C, Ribera JM, de la Rubia J, Carreras E.

Haematologica. 2009 Sep;94(9):1282-8. doi: 10.3324/haematol.2009.006924.

9.

Regulatory T-cells in the graft and the risk of acute graft-versus-host disease after allogeneic stem cell transplantation.

Wolf D, Wolf AM, Fong D, Rumpold H, Strasak A, Clausen J, Nachbaur D.

Transplantation. 2007 Apr 27;83(8):1107-13.

PMID:
17452902
10.

Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia.

Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, Jacobsen N, Ruutu T, de Lima M, Finke J, Frassoni F, Gluckman E; Acute Leukemia Working Party of European Blood and Marrow Transplant Group; Eurocord-Netcord Registry.

N Engl J Med. 2004 Nov 25;351(22):2276-85.

11.

Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.

Meisel R, Enczmann J, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Wernet P, Göbel U, Laws HJ, Dilloo D.

Klin Padiatr. 2005 May-Jun;217(3):135-41.

PMID:
15858704
14.

Predicting graft-versus-host disease in HLA-identical bone marrow transplant: a comparison of T-cell frequency analysis and a human skin explant model.

Dickinson AM, Sviland L, Wang XN, Jackson G, Taylor PR, Dunn A, Proctor SJ.

Transplantation. 1998 Oct 15;66(7):857-63.

PMID:
9798694
15.

A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: a focus on the incidence of graft-vs.-host disease and relapse.

Ustün C, Arslan O, Beksaç M, Koç H, Gürman G, Ozçelik T, Yilmaz B, Ilhan O, Akan H, Ozcan M, Demirer T, Uysal A, Konuk N, Arat M, Dilek I, Celebi H, Coskun HS.

Biol Blood Marrow Transplant. 1999;5(1):28-35.

16.

A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.

Couban S, Simpson DR, Barnett MJ, Bredeson C, Hubesch L, Howson-Jan K, Shore TB, Walker IR, Browett P, Messner HA, Panzarella T, Lipton JH; Canadian Bone Marrow Transplant Group.

Blood. 2002 Sep 1;100(5):1525-31.

17.
18.

Higher CD34(+) and CD3(+) cell doses in the graft promote long-term survival, and have no impact on the incidence of severe acute or chronic graft-versus-host disease after in vivo T cell-depleted unrelated donor hematopoietic stem cell transplantation in children.

Kałwak K, Porwolik J, Mielcarek M, Gorczyńska E, Owoc-Lempach J, Ussowicz M, Dyla A, Musiał J, Paździor D, Turkiewicz D, Chybicka A.

Biol Blood Marrow Transplant. 2010 Oct;16(10):1388-401. doi: 10.1016/j.bbmt.2010.04.001. Epub 2010 Apr 9.

19.

Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation.

Clave E, Busson M, Douay C, Peffault de Latour R, Berrou J, Rabian C, Carmagnat M, Rocha V, Charron D, Socié G, Toubert A.

Blood. 2009 Jun 18;113(25):6477-84. doi: 10.1182/blood-2008-09-176594. Epub 2009 Mar 3.

20.

Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.

Shaiegan M, Iravani M, Babaee GR, Ghavamzadeh A.

Transpl Immunol. 2006 Jan;15(3):223-7. Epub 2005 Nov 28.

PMID:
16431290

Supplemental Content

Support Center